Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness

NCT02739568 is registered in ClinicalTrials.gov with Bioprojet as lead sponsor.

NCT NCT02739568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02739568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness
Lead sponsor
Bioprojet
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2016
Completion date
April 30, 2020
Enrollment
389 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

excessive daytime sleepiness, obstructive sleep apnea